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ABSTRACT Cholesterol and cholesteryl esters are the predominant lipids of atherosclerotic plaques. To provide funda-
mental data for the quantitative study of plaque lipids in situ, crystalline cholesterol (CHOL) and CHOUcholesteryl ester (CE)
mixtures with other lipids were studied by solid-state nuclear magnetic resonance with magic-angle-sample spinning. Highly
distinctive spectra for three different crystalline structures of CHOL were obtained. When CHOL crystals were mixed with
isotropic CE oil, solubilized CHOL (-13 mol % CHOL) was detected by characteristic resonances such as C5, C6, and C3;
the excess crystalline CHOL (either anhydrous or monohydrate) remained in its original crystalline structure, without being
affected by the coexisting CE. By use of 13C-enriched CHOL, the solubility of CHOL in the CE liquid-crystalline phase (-8 mol
%) was measured. When phosphatidylcholine was hydrated in presence of CHOL and CE, magic-angle-sampling nuclear
magnetic resonance revealed liquid-crystalline CHOL/phosphatidylcholine multilayers with approximately an equal molar
ratio of CHOL/phosphatidylcholine. Excess CHOL existed in the monohydrate crystalline form, and CE in separate oil or
crystalline phases, depending on the temperature. The magic-angle-sampling nuclear magnetic resonance protocol for
identifying different lipid phases was applied to intact (ex vivo) atherosclerotic plaques of cholesterol-fed rabbits. Liquid,
liquid-crystalline, and solid phases of CE were characterized.
INTRODUCTION
Ischemic heart disease is a major cause of death and dis-
ability in many societies. The primary cause of heart disease
as well as of ischemic damage to the brain and other organs
is atherosclerosis, which results in narrowing of blood ves-
sels that feed these tissues. Although atherosclerosis is a
complex process that may have many causes, it is always
characterized by accumulation of lipids, mainly crystalline
cholesterol (CHOL) and CHOL/cholesteryl ester (CE), in
the intimal layers of vessels (Small, 1988). Knowledge of
the composition and physical chemistry of atherosclerotic
plaques is essential for understanding how these plaques
originate and mature and how reversal of the pathological
process may be achieved (Small, 1988). It is therefore
important to develop new techniques to characterize more
completely the chemical and physical aspects of atheroslerosis.
Physical techniques such as differential scanning calo-
rimetry, optical and electron microscopy, and x-ray diffrac-
tion provide specific data on certain aspects of the physical
chemistry of plaque lipids (Small, 1988). In general, these
methods do not directly identify the molecular species that
give rise to the physical observation. Newer methods such
as micro-Fourier-transform IR spectroscopy give informa-
tion about some chemical constituents, especially CE, and
their concentrations in plaques (Kodali et al., 1991). Stan-
dard high-resolution l 3C nuclear magnetic resonance
(NMR) spectroscopy can yield chemical, in addition to
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physical, information (Hamilton et al., 1979; Kroon et al.,
1982; Toussaint et al., 1994); however, detailed data are
obtained only for the liquid phase, and solid phases are not
detected. By use of solid-state 13C NMR with magic-angle-
sample spinning (MAS), it is possible to obtain high-reso-
lution spectra of liquid-crystalline and crystalline phases.
Polycrystalline lipids that have crystal structures with sym-
metrically inequivalent molecules exhibit distinguishable
peaks for the same carbon nuclei at different crystallo-
graphic sites (Guo and Hamilton, 1993, 1995a,b). MAS
NMR can be used to monitor the phase transitions, to detect
all the coexisting phases in mixtures of CE with different
acyl chains, and to determine the crystal structure of CE
(Guo and Hamilton, 1995a). In principle, it can provide
information about the structural organization, molecular
motions, and chemical composition in more-complex mix-
tures and biological samples.
To complete our development of MAS NMR approaches
for detection of lipids in plaques, we have studied pure
CHOL and mixtures of lipids that model plaque lipids by
13C MAS NMR. CHOL is a major constituent of plaques
and exists primarily in a crystalline form in mature plaques.
Following characterization of CHOL in its hydrated and
anhydrous forms, we examined in detail the interactions of
CHOL and CE in lipid mixtures of increasing complexity.
We show that 13C MAS NMR provides the most compre-
hensive physical and chemical description of such lipid
mixtures to date. Finally, we applied our MAS NMR pro-
tocol to the identification of lipids in an atherosclerotic
lesion from a New Zealand White rabbit artery. These
results demonstrated that MAS NMR permits a detailed,
nondestructive analysis of intact excised atherosclerotic
plaques.
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EXPERIMENTAL
Materials
CHOL, CE [cholesteryl palmitate (CP), cholesteryl oleate (CO), cho-
lesteryl linoleate (CL)] and triolein (TO) were purchased from Nu-Chek
Prep (>99% pure; Elisian, MN). Egg phosphatidylcholine (eggPC) and
1,2-dipalmitoyl-sn-3-glycero-phosphocholine (DPPC) were purchased
from Avanti Polar Lipids (>99% pure; Alabaster, AL). The impurity
contents of TO, CE, eggPC, and DPPC were confirmed by TLC to be
<2-3%, and the lipids were used as received. After NMR experiments,
lipid mixtures were examined by TLC, and there was no significant
increase in the impurity content for CHOL, CE, TO, and DPPC. However,
eggPC degraded significantly (10-15%) after prolonged data acquisition at
elevated temperature, and in these cases DPPC was substituted for eggPC.
Anhydrous CHOL was recrystallized from dry ethanol, and trace
amounts of ethanol were removed under vacuum for 24 h. We obtained
CHOL monohydrate (ChM) by first dissolving CHOL in pure ethanol and
then adding deionized water drop by drop until a white precipitate ap-
peared. The resulting suspension was heated in a water bath until a clear
solution appeared. This process was repeated until the heating no longer
dissolved the precipitate; we then added a drop of ethanol to retain a clear
solution, which was allowed to cool gradually to room temperature. The
final solution, usually containing -30% water by volume, was stored at
4°C. After crystallization, the solid was soaked in a large quantity of cold
deionized water to remove the residual ethanol. The supernatant water was
replaced three times, and the solid was then stored in water at 4°C before
use. The various crystalline forms were confirmed by their thermal phase
transitions detected by differential scanning calorimetry and by their char-
acteristic x-ray powder diffraction pattern (Small, 1986).
Sample preparation
Anhydrous CHOL (ChA) was ground into a powder and loaded into the
MAS NMR sample rotor directly. The ChM was ground under water and
loaded into the rotor in the presence of excess water. A CE mixture of
CO/CP/CL (69:17:14 wt %) was prepared to model the lipid deposit of
CHOL-fed rabbit artery (see below); the phase behavior of this mixture has
been presented elsewhere (Guo and Hamilton, 1995a). This CE mixture is
used throughout the study reported here unless otherwise mentioned. We
prepared ChA/CE and ChM/CE mixtures by weighing the desired amount
of each component and mixing the components either at a temperature
above the CE melting point or in CHC13 solution followed by drying under
vacuum for 12 h. Samples containing ChM were prepared in the presence
of excess water. We prepared a mixture of ChA, CE, and eggPC or DPPC
by mixing the desired amount of each component in CHC13, forming a thin
film under N2, and then removing trace amounts of CHC13 under vacuum
for 12 h. This lipid mixture was hydrated with deionized distilled water.
The quantity of water was chosen to make a ratio of PC/(PC + water) =
30 wt %. The mixture was placed under N2 and freeze-thawed (-20°C to
55°C) 10 times, equilibrating each time for 10 min at 55°C (where isotropic
CE and liquid-crystalline DPPC coexisted) to allow maximum incorpora-
tion of cholesterol. The sample was used for MAS NMR experiments soon
after preparation.
Thoracic aorta tissue was obtained from New Zealand White rabbits fed
with a cholesterol-rich diet (0.5% wt/wt cholesterol and 4% vol/wt peanut
oil added to Purina rabbit chow) for 11 weeks. At the time of sacrifice, the
cholesterol-fed rabbit used for these studies had a body weight of 3.6 kg
and a plasma cholesterol level of 1270 mg/dl, much greater than the range
in normal rabbits (50-70 mg/dl). Euthanasia was performed by adminis-
tration of sodium pentobarbital and exsanguination according to a protocol
approved by the Boston University Medical Center Institutional Animal
Care and Use Committee. The lipid compositions of these lesions were
measured after the NMR experiments by standard chemical analysis (Nolte
et al., 1990), and the results are given in Tables 1 and 2.
NMR measurements
MAS NMR experiments were performed on a Bruker (Billerica, MA)
AMX300 NMR spectrometer equipped with solid-state NMR accessories.
Samples were held in 7-mm Zirconia rotors. A spherical Kel-F insert was
used to cover the sample to prevent leakage and promote spinning. Total
sample volume was 100 I.d MAS NMR with high-power decoupling and
without cross-polarization [direct polarization (DPMAS)] and MAS NMR
with high-power decoupling and with cross-polarization (CPMAS) were
used for identification of lipids in multiphase mixtures and the tissue
samples. All spectra were obtained with a 5-, s 900 pulse width, 50-kHz
spin-lock field and decoupling power, and a 5-s pulse interval. Typical CP
contact time was 1 ms, with exceptions as indicated in the corresponding
figures below. MAS spinning rates were 4.0-4.5 kHz for the crystalline
samples and 1.5-2 kHz for the liquid and liquid-crystalline samples. The
13C chemical shifts were referenced to the carbonyl carbon resonance of
glycine [176.06 ppm from (CH3)4Si] as an external reference. Spectra were
typically obtained over 20003 time-domain points and were zero filled to
8,192, giving a spectral digital resolution of -2.0 Hz. All spectra were
processed without line broadening unless otherwise noted. Sample temper-
atures were controlled to within 1°C with a Bruker B-VT-1000 variable-
temperature unit. The probe temperature was calibrated as described pre-
viously (Guo and Hamilton, 1993, 1995a,b,c). Samples were allowed to
equilibrate at the desired temperature for 15-20 min before data acquisition.
Differential scanning calorimetry
Experiments were carried out with a Perkin-Elmer DSC-7 instrument
(Norwalk, CT). Samples (1.5-5 mg) were sealed in a stainless-steel pan.
An empty pan was used as a reference sample. Heating and cooling rates
were 5°C/min. The instrument was calibrated by use of the data obtained
for high-purity standard material (indium).
X-ray powder diffraction
Patterns were recorded with nickel-filtered CuK-a radiation from an Elliot
GX-6 rotating-mode generator (Elliot Automation, Borehamwood, UK)
equipped with cameras using Franks double-mirror optics (Franks, 1958).
The samples were packed into 1.0-mm-diameter Lindeman capillaries
(Charles Supper, Natick, MA), sealed, and examined in variable-tempera-
ture sample holders. The sample-film distance was calibrated with the data
of a standard material (crystalline cholesteryl myristate).
TABLE I Lipid mass (mg) of the rabbit aortic sections
Sample
Dry tissue Total lipid CE TG CHOL Phospholipid
Control 26.5 1.00 0.004 0.05 0.17 0.65
Lesion 29.1 6.77 2.82 0.25 1.61 1.73
The composition of the atherosclerotic lesion is similar to that of previously published compositions of lesions from CHOL-fed NZW rabbits (Nolte et al.,
1990).
2858 Biophysical Journal
Solid-State NMR of Lipids in Atherosclerosis
TABLE 2 Total mol % distribution of acyl chains of the rabbit aortic sections
Sample
16:0 16:1 18:0 18:1 18:2
Control 31 21 19 26 3
Lesion 14.4 4.4 4.3 58.5 11.6
The acyl chain composition of the lesion sample served as a model for CE mixtures used in previous study (Guo and Hamilton, 1995) and in this study.
Microscopy
Experiments were performed on a Leitz-Dialux microscope fitted with a
polarizer and heating stage 80 (Leitz/Wild, Burlington, MA). Photomicro-
graphs were taken with a Nikon Microflex UFX camera system (Nikon,
Inc., Garden City, NJ) with 35-mm film (Kodak Ektachrome ASA 200).
RESULTS AND DISCUSSION
13C MAS NMR features of crystalline CHOL
Pure cholesterol can exist in three thermodynamically stable
crystalline forms: monohydrate (ChM), low-temperature
anhydrous (ChAl), and high-temperature anhydrous
(ChAh). ChAl and ChM convert to ChAh at 38°C and 85°C,
D. Static cholesterol monohydrate (25C)
C. High-temp anhydrous form of cholesterol (50C)
B. Low-temp anhydrous form of cholesterol (250C)
A. Cholesterol monohydrate (25°)
C 14/17
C5 C6 C3
respectively. The CPMAS spectra of ChM, ChAl, and
ChAh are shown in Figs. 1 A, 1 B, and 1 C, respectively. For
comparison, a static sample spectrum of ChAh (obtained
with the same experimental conditions but without spin-
ning) is shown in Fig. 1 D. Without MAS, the spectrum was
broad and featureless even after high-power decoupling and
cross-polarization transfer were applied. With CPMAS,
high-resolution spectra were obtained, and multiple signals
of the same carbon representing the crystallographically
inequivalent molecules were resolved for various carbon
atoms, such as C5, C6, C3, C14/17, C9, and C18. Line
widths as low as 10 Hz were observed, and peaks separated
by as little as 0.2 ppm were resolved. Other steroid carbons
13 120
145 130 120 70 60 40 0-F-10
FIGURE 1 The 13C CPMAS of (A) cholesterol monohydrate, (B) a low-temperature form of anhydrous cholesterol, (C) a high-temperature form of
anhydrous cholesterol, and (D) the same sample as in (C) but without spinning. Selected CHOL resonances are identified by the standard numbering system
for CHOL. The number of scans was 1000 for each spectrum.
I I I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
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might also give multiple signals, but they are superimposed
in a relative small frequency region and thus are not well
resolved from each other. The chemical shifts of selected
carbons are listed in Table 3.
For ChM, carbons such as C5, C6, C9, and C18 had two
peaks with approximately equal intensities (Fig. 1 A). In the
crystalline structure of ChM the monohydrate molecules
exist in bilayers, with the hydroxyl arranged in sheets
through H-bonding (Craven, 1976, 1979). Although there
are eight crystallographically different molecules in the unit
cell, the shieldings on the molecules in each half of the
bilayer are similar because of the sublattice pseudosymme-
try (Craven, 1979). The observation of two sets of signals
for C5, C6, and C 18 reflects the inequivalent packing in the
two halves of the bilayer. Only one broad but symmetric
peak was observed for C3 (Fig. 1 A), because the shieldings
on C3 in different molecules throughout the H-bonded
network are not so distinctive. H-bonding also reduces the
molecular motions of C3, resulting in line broadening.
In the crystal form ChAl, the C5, C6, C18, and C3
carbons each had multiple peaks with varying peak inten-
sities (Fig. 1 B). For C5, a downfield group contained four
well-separated peaks of approximately the same intensities
(140.8-141.7 ppm), and an upfield group contained two
peaks at 139.2 and 138.5 ppm (Table 3). The peak at 138.5
ppm has approximately the same intensity as each of those
in the downfield group, whereas the peak at 139.2 ppm is
approximately three times as intense. Thus, six nonequiva-
lent signals for the C5 were resolved from the eight sym-
metrically inequivalent molecules in the single-crystal
structure (Shieh et al., 1977). In addition, six peaks were
well resolved for C6 and C1 8, five with nearly the same
intensity and the other approximately three times as intense.
With negative line broadening applied to the Fourier trans-
form to enhance resolution, an additional small peak was
revealed nearby the intense peak (Fig. 1 B, inset). For C3,
one narrow downfield peak and one broad upfield peak
were observed. According to the single-crystal data, the
eight symmetrically inequivalent molecules are H-bonded
in two separated chains parallel to each other (Shieh et al.,
1977). Inasmuch as the chemical shift of C3 is affected by
H-bonding, the observation of two different peaks for C3
suggests different molecular interactions near the polar
headgroup between the two chains.
ChAl converts to ChAh at 38°C, and ChM to ChAh at
85°C. Both transitions were accompanied by significant
spectral changes. The CPMAS spectra obtained for ChAh
formed from the two crystals were the same (Fig. 1 C). In
the C5 region, multiple peaks with slightly different chem-
ical shifts were observed; peaks on the upfield have similar
intensities, whereas the two most downfield peaks are much
more intense. For C6, five peaks were observed, all slightly
broader than those observed for the ChAl form, with two
peaks in the middle approximately two to three times more
intense. The C18 carbon also gave multiple peaks with a
complicated intensity distribution. The C3 region consisted
of a broad envelope of resonances. The phase transition
from ChAl to ChAh is accompanied by the variation of the
isooctyl chain conformations and the reorientation of the
steroid rings, leading to a more complicated structure with
16 inequivalent molecules in the unit cell (Hsu and Nord-
man, 1983). Fig. 1 B and C reveals multiple resonances with
varying intensities for C5, C6, and C18 carbons, corre-
sponding to these molecular rearrangements. Although the
x-ray powder diffraction patterns of ChAl and ChAh are
rather similar (Loomis et al., 1979), the 13C MAS NMR
resonance features are significantly different for these two
crystals, implying that MAS NMR is more sensitive to the
changes in molecular arrangements in the crystalline struc-
tures.
In additional temperature studies, CPMAS spectra
showed that ChAh formed by heating ChAl readily con-
verted back to ChAl right below the phase transition
(-38°C), whereas ChAh formed by heating ChM remained
metastable at 25°C for >4 h before eventually converting to
the ChAl crystalline form. On the other hand, ChM exposed
to dry room atmosphere overnight gave a 13C CPMAS
spectrum the same as that of ChAl, implying complete
dehydration, even though the crystals still had the platelike
appearance characteristic of ChM morphology as viewed by
the optical microscopy.
CHOL crystals under the polarizing microscope
Large crystals of ChM and ChAl grown under ideal condi-
tions (solvent, concentration, and temperature) are well dis-
tinguishable by optical polarizing microscopy (Small,
1986). ChM has a platelike (Fig. 2 A) and ChAl a needlelike
(Fig. 2 C) appearance. However, under nonideal conditions
the identification by optical microscopy becomes ambigu-
ous. For example, heating the crystals of ChAl or ChM
converted them to ChAh at 38°C and 85°C, respectively.
Because of the lack of a recrystallization medium, the newly
formed ChAh were small, and the overall appearance was
difficult to discern. Fig. 2 B shows the same view as Fig. 2
A after incubation of the crystal at 90°C for 3 h. The crystal
seems to have broken into small pieces, but the morphology
TABLE 3 Chemical shifts (ppm) of C3, C5, and C6 resonances of pure CHOL in various crystalline forms
Crystal form C3 C5 C6
ChM 71.8 142.4, 140.9 120.8, 120.3
ChAl 71.4,70.6, 70.3 141.7, 141.2, 141.0, 140.8, 139.2, 138.5 122.9, 122.7, 122.5, 122.2, 121.8, 121.5, 121.1
ChAh 69.8-72.1 141.7, 141.4, 141.1, 140.7, 139.9, 139.3, 138.8, 138.6 123.4, 122.9, 122.1, 121.6, 121.2
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FIGURE 2 Photomicrograph (160X) of (A)
cholesterol monohydrate recrystallized from
an ethanol/water mixed solvent, (B) the same
crystal dehydrated by incubation at 90°C for
2 h and then cooled to 25°C, (C) a low-tem-
perature form of anhydrous cholesterol crystal
recrystallized from diethyl ether, (D) a low-
temperature form of anhydrous cholesterol
crystal obtained directly from the manufac-
turer. The MAS NMR spectra of samples (B)-
(D) at 25'C are identical (see Fig. 1 B).
of the newly formed ChAh is unclear. When the ChAl
crystals shown in Fig. 2 B were heated to 50°C for 1 h, their
appearance was not changed (not shown). Fig. 2 D shows
the powdered cholesterol sample received from the manu-
facturer, which also does not reveal the crystalline structure.
By MAS NMR this sample was identified as ChAl. There-
fore, the application of optical microscopy for identification
of crystalline forms of CHOL has significant limitations. In
addition, when the crystallization occurs in biological sam-
ples the morphology will be further affected by many other
influences, which could make the microscopy identification
even more difficult. For example, needle-shaped crystals in
CE-loaded macrophages had a melting point close to that of
CHOL monohydrate (85°C). Electron micrographs showed
membranes surrounding the crystals. Proof that these crys-
tals were CHOL required their isolation and purification
followed by TLC analysis (Tangirala et al., 1994).
Although x-ray diffraction can identify the different
CHOL crystalline forms, the diffraction pattern contains
overlapping data from all other coexisting structures when a
complicated sample of mixed lipid species is present. With-
out purification and isolation, individual species and their
corresponding structure might not be detected. However,
with MAS NMR and with selected pulse programming
conditions, both chemical composition and physical phases
can be identified semiquantitatively without sample disrup-
tion (Guo and Hamilton, 1993, 1995a,c). The unique spec-
tral features of CHOL in the three different crystalline
Guo and Hamilton 2861
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structures (Fig. 1) provide a basis for the identification of
CHOL crystal forms in biological samples by MAS NMR.
MAS NMR of CHOL/CE mixtures
To study the interactions and physical states of CHOL in
mixtures with CE, we incorporated anhydrous ChAl (24 wt
%) into the model CE mixture for the rabbit atherosclerotic
plaques (CE with CO/CP/CL = 69:17:14). The sample was
mixed at 550C, in the isotropic phase of CE, for at least 2 h
before the NMR experiments to ensure that the solubiliza-
tion of CHOL in CE oil reached equilibrium (Miller and
Small, 1982). A DPMAS 13C spectrum of this mixture at
600C showed signals for isotropic CE and CHOL (Fig. 3A).
Although most of the CHOL signals are superimposed with
CE signals, the C3, C5, and C6 peaks are well separated and
served to identify CHOL in the isotropic phase (Hamilton
and Cordes, 1978) (Table 4). The peak intensity of
CHOL/CE was 0.16 for the C5 and 0.15 for the C6 carbons,
representing a solubility of CHOL in CE oil of - 13 mol %
(5.2 wt %), close to the reported solubility maximum (5.6 wt
%; North et al., 1978). The same proportion of CHOL/CE is
found in the hydrophobic core of plasma high-density
E. CE-FC mixture in
anhydrous crystall
FIGURE 3 13C MAS NMR spectra of a D. Smectic phase of(
binary mixture of CE and CHOL (24 wt % (DPMAS)
CHOL) at various temperatures: (A) isotro-
pic phase at 60'C, (B) a high-temperature
form of anhydrous crystalline cholesterol in
coexistence with the isotropic phase at 60'C,
(C) the cholesteric liquid-crystalline phase at C. Cholesteric phase
45'C, (D) the smectic liquid-crystalline
phase at 42'C, and (E) a solid-state mixture
of CE and CHOL at 25'C. The spectra in A,
C, and D were obtained with DPMAS, and
the spectra in B and E were obtained with
CPMAS. Selected resonances are identified B. High-temperature:
by the standard numbering system of the
CHOL ring system and by C=O (CE),
C==C (unsaturated carbons of oleic and lino-
leic acid), and coCH3 (terminal fatty acid
CH3). The number of scans was 4096 for
each spectrum.
TABLE 4 Chemical shifts (ppm) of C3, C5, and C6
resonances of CHOL in various lipid mixtures
Lipid Phase C3 CS C6
Isotropic CE 71.03 141.45 120.82
Sm CE 70.88 141.42 120.73
Isotropic CE with TO 71.09 141.43 120.84
Sm CE with TO 70.97 141.36 120.72
DPPC/CHOL bilayer 71.18 142.09 120.83
(Hamilton and Cordes, 1978) and low-density (Hamilton et
al., 1979) lipoproteins. Higher temperatures did not result in
significant changes in the relative peak intensities of CE and
CHOL, whereas temperatures (51-55°C) near the crystal-
line-isotropic transition temperature of 50°C resulted in
differential line broadening of the C5, C6, and C3 peaks of
both CE and CHOL signals, as reported before (Hamilton et
al., 1977).
The peak intensity data of Fig. 3 A showed that the major
portion of the CHOL in the mixture with CE was not
observed in the DPMAS spectrum, which detects liquid and
liquid-crystalline phases. To identify CHOL in the solid
phase we carried out a CPMAS experiment to enhance
solid state, with low-temp form of
line FC detected (CPMAS)
150I 1 5I 100, 7
ppm 150 125 100
. - .T-- 1-
75 50 25
r-
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signals for solid components and to filter out the signals for
liquid components (Guo and Hamilton, 1995a,c). The spec-
trum at 60'C (Fig. 3 B) was the same as that of ChAh (Fig.
1 C), indicating the excess CHOL is in a crystalline form
that is indistinguishable from pure ChAh at this tempera-
ture. The spectrum in Fig. 3 B shows the ability of the
CPMAS method to detect lipid in a crystalline state without
interference from signals of lipids in the liquid state, the
major phase of this mixture.
Temperature-dependent spectra between 50'C and 250C
showed that the solubilized CHOL had little effect on the
phase behavior of the CE mixture, and the DPMAS spectra
resembled those previously reported for CE without CHOL
(Guo and Hamilton, 1993). When the sample was cooled,
the cholesteric (Ch*) phase of CE was detected at 450C
(Fig. 3 C), and the smectic (Sm) phase at 420C (Fig. 3 D).
In both cases the coexisting crystalline CHOL was in the
ChAh form, as detected by CPMAS (not shown). Direct
detection of the small amount of CHOL solubilized in the
Ch* liquid crystalline phase of CE was difficult because of
the characteristic line broadening of the CE C5, C6, and C3
peaks in the Ch* phase (Guo and Hamilton, 1993). How-
ever, when the peaks became narrow again in the smectic
phase, signals were observed for the C5, C6, and C3 peaks
representing CHOL solubilized in the Sm phase, as mani-
fested by their chemical shifts. On cooling the Sm phase to
250C, the mixture solidified; the spectrum (Fig. 3 E) re-
vealed a solid-state mixture of the low-temperature CHOL
form (ChAl) and a solid solution of CE (Guo and Hamilton,
1993).
To study the solubilization of CHOL in the liquid-crys-
talline CE we replaced the CHOL component with CHOL
containing 13C enrichment at the C3 position. Incorporation
of CHOL into the liquid-crystalline phases was clearly
demonstrated by DPMAS (Fig. 4 A-C). The solubility of
CHOL in the Sm phase was -8 mol %, based on the relative
peak intensities after correction for 13C enrichment (Fig. 4
C), compared with 13 mol % in the isotropic phase (Fig. 4
A). Although line broadening in the Ch* phase precluded
quantification of the CHOL solubility, the intense broad
peak of CHOL centered at 72.5 ppm clearly indicated sub-
stantial incorporation of CHOL into the Ch* phase of CE
(Fig. 4 B).
To our knowledge, direct detection of CHOL in liquid-
crystalline CE phases has not been reported before. Results
of Fig. 4 further demonstrate that the MAS NMR can
readily and directly provide information on the chemical
compositions in a liquid-crystalline phase, data that are
difficult to obtain by other methods.
A mixture with the same CHOL/CE ratio as above, but
with ChAl replaced by ChM, was prepared in the presence
of excess water. The DPMAS spectra of the isotropic and
liquid-crystal phases of this ChM/CE mixture were the same
as those for the mixture with anhydrous CHOL (Fig. 3).
Notably, the chemical shifts of CHOL C3, C5, and C6
carbons were identical in both cases (Table 3). This implies
+that theoun waermoeclewaIls when- theChM-
(C) Smetic phase (40'C)
C3(CHOL)
C3(CE)I
(A) Isotropic phase (550C)
PPM 75 70 65
FIGURE 4 '3C DPMAS spectra (60-80 ppm) of CE and CE-incorpo-
rated cholesterol with '3C labeling at the C3 position. The number of scans
was 800 for each spectrum.
dissolved in the hydrophobic CE oil. The pool of CHOL not
dissolved in the CE oil was present as the monohydrate
form, as shown by the characteristic spectrum (as in Fig. 1).
To assess whether the CE composition affects the solu-
bility of CHOL, pure CO and a CO/CL (25 wt % CL)
mixture were used for parallel studies as above. The results
of MAS NMR experiments showed that these changes in the
CE composition did not significantly affect the CE/CHOL
interactions in the fluid phases (data not shown).
CHOLUCE/TO mixtures
Atherosclerotic plaques may contain small amounts of tri-
glyceride (TG), which can significantly alter the phase
behavior of the CE (Croll et al., 1985; Small, 1988). Levels
of TG as low as 4 wt % remove the Ch* phase transition of
the CE, and levels of >22% abolish all liquid-crystalline
transitions (Hamilton et al., 1977). As a model system for
plaques with TG, 10 wt % TO was added to the CE/CHOL
mixture prepared as above. The melting point of the mixed
system determined by MAS NMR (50'C) was 30C lower
than that for CE/CHOL without TO. The DPMAS spectrum
of the isotropic phase at 60'C (Fig. 5 A) closely resembled
that of the CE/CHOL mixture without TO (Fig. 3 A), except
for the presence of peaks from the TO(l, 3) carbonyl and
glycerol backbone carbons of TO. The TG(2) carbonyl is
superimposed with the CE carbonyl signal. As revealed in
the CS, C6, and C3 regions (Fig. 5 A), there was no signif-
icant enhancement of CHOL peaks relative to the CE peaks
compared with the results shown in Fig. 3 A, implying that
TO did not increase the solubility of CHOL in the isotropic
phase. The crystal form of the coexisting excess CHOL
Guo and Hamilton 863
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(D) The TO rich oily phase with CE (DPMI
All ,A .V-IV
250C
FIGURE 5 13C MAS NMR spectra of
a ternary mixture of CE and CHOL and
TO at various temperatures: (A) the iso-
tropic phase at 60°C, (B) the Sm liquid-
crystalline phase at 42°C, (C) a solid-
state mixture of CE and CHOL at 250C,
and (D) TO oil in equilibrium with the
solid mixture of CE and CHOL at 250C.
Spectra identifying liquid and liquid-
crystalline phases [(A), (B), and (D)]
were obtained with DPMAS, and that
identifying the crystalline phases (C)
with CPMAS. Resonances for the glyc-
erol backbone of TO are designated
glyCH and glyCH2 in the expanded in-
sets of (A) and (D). Other peaks are des-
ignated as in previous figures. The num-
ber of scans was 4096 for each spectrum.
(C) Solid mixture of solid CE/CHOL (CPMAS)
250C
(B) Sm CE with TO (DPMAS)
35°C
.I IL 1.
(A) Isotropic CE with TO (DPMAS)
6 + >C=C< 60°C
CP5HIIC
C5(CHOL) 16(CHOL)
ppmr 150 I 00
(ChAh) was also unaffected by the TO, as indicated by the
identity of the CPMAS spectrum (not shown) compared
with that in Fig. 1 B.
On cooling, the isotropic phase transformed directly to
the Sm phase at 43°C, and the Ch* phase was not
observed, as reported (Hamilton et al., 1977). The inte-
grated peak intensities in the DPMAS spectrum of the Sm
phase (Fig. 5 B) gave a solubility of 12 mol % of CHOL
relative to CE, higher than the solubility without TO.
Because interactions between CHOL and TO are rather
weak (the solubility of CHOL in TO oil is only 0.5 wt %;
Miller et al., 1982), TO might create structural defects in
the CE Sm phase structure to accommodate solutes such
as CHOL.
With further cooling to 25°C, the major portion of CE
solidified to form a mixture of crystalline CE and amor-
phous CE (Guo and Hamilton, 1993), as indicated by the
CPMAS spectrum (Fig. 5 C). To observe the fluid phases,
we obtained a DPMAS spectrum of this mixture (Fig. 5 D).
Narrow signals from the carbonyl and glycerol carbons of
TO were readily observed, and a narrow C=CO from CE was
also observed downfield from a broad C==O signal repre-
senting the solid state (Fig. 5 D, inset). The narrow peaks in
Fig. 5 D probably represent a separate TO-rich oil phase,
containing some CE and coexisting with the solid CE/
CHOL phase.
Following similar experimental protocols, by varying
CHOL from anhydrous to monohydrate and substituting CO
or CO/CL (25 wt % CL) for the CE mixture we showed that
the solubility of CHOL in the isotropic and Sm phases of
CE was not significantly affected by the change of CE
composition or the hydration state of CHOL. The crystalline
50
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forms of CHOL (ChAl, ChAh, and ChM) were also not
affected by the addition of TO in any of the mixtures.
CHOL/CE/phospholipid mixtures
Lipids deposited in atherosclerotic plaques originate in part
from low-density lipoproteins, triglyceride-rich remnant li-
poprotein, and Lp(a) that contain phospholipid in addition
to CE, CHOL, and TG (Bottalico et al., 1993; Small, 1988;
Hamilton et al., 1978). In addition, the lipids in plaques are
in a tissue environment that contains cell membrane, whose
predominant lipids are phospholipids and CHOL. The in-
teractions of CHOL and phospholipids in a bilayer system
were recently characterized in a detailed multinuclear solid-
state NMR study of DPPC/CHOL mixtures (Guo and Ham-
ilton, 1995c). To complete our investigations of the model
systems for plaques, we studied three samples that com-
prised phospholipids, CHOL, and CE, with the following
mol % composition: CHOL/CEl/eggPC = 1:1:1; CHOL/
CE1/DPPC = 1:1: 1; and 2:1:1. All samples were hydrated
above their gel-to-liquid-crystalline phase transition temper-
ature in excess water. With the chosen CHOL contents, both
eggPC and DPPC exist in a liquid-crystalline state at 25°C
(McMullen et al., 1993), and CHOL can incorporate into the
bilayer up to a 1:1 mol ratio (Bourges et al., 1967; Philips,
1990; Guo and Hamilton, 1995c). The phase diagrams
(Bourges et al., 1967) further predicted that CE and unin-
corporated CHOL would be in a solid state at this temper-
ature. In accord with predictions, the DPMAS spectrum (not
shown) of each of these samples resembled published spec-
tra of liquid-crystalline phospholipid/CHOL multilayers
(Forbes et al., 1988; Guo and Hamilton, 1995c). The coex-
isting solid-state CE or CHOL was not detected. Under the
experimental conditions used there were no significant
spectral differences between eggPC/CHOL and DPPC/
CHOL mixtures, except for the presence of the signals
reflecting the chain unsaturation of eggPC. Because eggPC
is less stable at elevated temperature, we substituted DPPC
for eggPC to perform temperature-dependent studies. In a
CHOL/CE/DPPC (1:1:1) mixture at 60°C, CE melted to
form an isotropic phase and was detected in the DPMAS
spectrum by the characteristic C==O, C5, C6, and C3 res-
onances (Fig. 6A). The C5 and C6 peaks of CHOL were
broader than the corresponding CE peaks, a factor that may
(D) Isotropic CE and 1:2 PC/CHOL (CPMAS, 10 ms contact time)
60°C
(C) Isotropic CE and 1:2 PC/CHOL (CPMAS, 0.5 ms contact time)
600c
(B) Crystalline CE and 1:1 PC/CHOL (CPMAS)
'ppm
,_
ppm 160 140 120 100 80 60 40 20
FIGURE 6 13C MAS NMR spectra of mixtures of CE and CHOL and phospholipids: (A) a liquid-crystalline eggPC/CHOL bilayer and isotropic CE at
60°C; (B) a solid-state mixture of CE and a liquid-crystalline DPPC/CHOL bilayer; (C) a crystalline CHOL monohydrate at 60°C in coexistence with
DPPC/CHOL bilayers and isotropic CE, this spectrum obtained with a 0.5-ms cross-polarization contact time; and (D) the same as in (C) but with 10-ms
contact time. Spectrum (A) was obtained with DPMAS, and spectra (B), (C), and (D) were obtained with CPMAS. The number of scans was 4096 for each
spectrum.
r _*1
-,I
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hinder detection of CHOL in tissues (see below). The sec-
ond model mixture with DPPC contained excess CHOL
(CHOL/CE/DPPC = 2:1:1) and is predicted to have a
bilayer phase comprising mainly DPPC and CHOL, a crys-
talline phase of CHOL, and a liquid or solid phase (tem-
perature dependent) of CE with some CHOL (Bourges et
al., 1967). The CPMAS spectrum at 25°C showed the
coexistence of liquid-crystalline DPPC/CHOL with solid-
state CE and ChM (Fig. 6 B). Because most of the CHOL
signals are superimposed with CE signals, the spectral fea-
tures of ChM were not clear in this spectrum. When the CE
phase was melted, the CE signals were fully suppressed
from the CPMAS spectrum. At 60°C, when we used a short
contact time (0.5 ms) to attenuate the mobile DPPC/CHOL
bilayer signals, the CPMAS spectrum (Fig. 6 C) was dom-
inated by signals of crystalline ChM, and the liquid-crys-
talline signals were largely undetected, except for the peak
from the main acyl chains at -30 ppm. A CPMAS spectrum
with a longer contact time (10 ms), which allows the cross-
polarization transfer between nuclei with moderate or weak
dipolar coupling (the bilayer phase), showed both ChM and
a liquid-crystalline DPPC/CHOL phase (Fig. 6 D). Thus, by
varying the contact time, one can observe either the crys-
talline phase alone or both crystalline and liquid-crystalline
phases.
In the fluid phases (liquid-crystalline and isotropic) most
of the steroid and isooctyl carbons of CE and CHOL were
superimposed, but well-separated peaks were observed for
C5, C6, C18, and C3 (Fig. 6 A). Also, separate fatty acyl
wCH3 peaks were observed for CE and PC. The CE signals
in Fig. 6 A were identified by the characteristic chemical
shifts of CE (Guo and Hamilton, 1993) and also by com-
parison with the spectrum of DPPC/CHOL multibilayers
without CE signals (Guo and Hamilton, 1995c). The solu-
bility of CE in hydrated liquid-crystalline phospholipid is
expected to be very small (Hamilton et al., 1983; Spooner et
al., 1986), and signals from this pool of CE were not
observed.
Spectral features of rabbit arterial tissues
By making use of the data from model systems and the
protocols developed to monitor different phases and chem-
ical constituents in lipid mixtures, we studied the lipids in
atherosclerotic plaques dissected from cholesterol-fed New
Zealand White rabbits. Such plaques serve to test our pro-
tocol for distinguishing different phases before application
of the method to human plaques. They are also particularly
suitable samples for MAS NMR experiments because most
of the CE are not melted at body temperature (Nolte et al.,
1990) and conventional 'H NMR spectra show severely
broadened signals unless high temperatures are used (Kroon
et al, 1982).
As a control sample, a segment of normal aortic tissue
without visible plaques was studied. The DPMAS spectrum
at 37°C showed only weak signals from plasma membranes
and mobile groups on proteins (Fig. 7 A). For a segment of
aortic tissue with observable plaques, the spectrum without
MAS was dominated by TG signals (Fig. 7 B). Although a
weak signal at 54.3 ppm was seen from the choline methyl
groups of choline-containing phospholipids, the prominent
signals characteristic of TG (carbonyl and glycerol) suggest
that most of the acyl chain signals are contributed by TG.
This spectrum, which is the same as would be obtained by
conventional high-resolution NMR, suggests that most of
the CE is not in a liquid phase at 37°C and thus is not mixed
with the TG (see below).
In the DPMAS spectrum (Fig. 7 C) numerous narrow
steroid ring signals were observed. The chemical shifts of
the C==O, C==C, C5, C6, C3, and C18 are characteristic of
CE in a liquid-crystalline phase. Signals from CHOL and
other lipids are not detected. To investigate possible coex-
isting solid-state lipid components, we used CPMAS to
enhance signals from solid phases and simultaneously sup-
press signals from liquid and liquid-crystalline phases (see
Fig. 6). The spectrum (Fig. 7 D) showed significant steroid
ring carbon signals; the absence of TG signals showed that
noncrystalline phases were well suppressed. The unsatura-
tion revealed in the olefinic region shows a single signal
characteristic of oleic acid, and the signal from linoleic
groups seen in the spectra of both Fig. 7 B and 7 C is not
seen. The observation of the oleoyl chain suggested that the
steroid signals observed in Fig. 7 D originated from CE
mixtures. When this sample was heated to 47°C, the signals
for the solid lipid largely disappeared (spectrum not shown),
confirming that the solid phase observed in Fig. 7 D was
mainly a CE solid solution. Some crystalline CHOL may
contribute to the spectrum in Fig. 7 D and be largely
obscured by the CE signal (see below).
It is important to note that the present spectra represent
significant improvements in detection of plaque lipids, as
judged by the CE component. The DPMAS spectrum of CE
in the rabbit plaque containing 2.8 mg of CE (Fig. 7 C)
shows signal-to-noise ratios comparable with those of a
conventional NMR spectrum of a human plaque containing
26 mg of CE and obtained in approximately the same time
period (Hamilton et al., 1979). Unesterified cholesterol was
not detected in the MAS NMR spectra of rabbit plaques.
Although the plaque sample (Table 2) contained an equimo-
lar ratio of CHOL and CE (CHOL/CE/phospholipid =
2:2:1, in moles), several factors effectively dilute the CHOL
signals relative to CE signals. The structural environments
of CHOL are more heterogeneous than is CE. The pools of
CHOL include the lamellar phase of cell membranes and
phospholipids deposited in the plaque, crystals, CE solubi-
lized, and possibly protein bound (Small, 1988). Moreover,
the model mixture of 1:1:1 CHOL/CE/PC (Fig. 6 A) showed
broadening of CHOL resonances in the lamellar phase (e.g.,
C5 and C6) relative to the corresponding CE resonances.
Comparison of the choline methyl resonance in the plaque
spectrum (Fig. 7 C) and in the model system spectrum (Fig.
6 A) shows a greatly reduced choline signal from the tissue.
Based on this signal, the signals for CHOL in the bilayer
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D. Early lesions, solid solution ofCE (CPMAS)
.1 X>C=C<(oleyl)
FIGURE 7 13C MASNMR spectra
of an atherosclerotic plaque dissected
from a CHOL-fed rabbit: (A) MAS
NMR spectrum of a normal rabbit
artery, (B) the oily phase of a rabbit
plaque detected by off-magic angle
spinning, (C) the oily phase and the
liquid-crystalline phase in the plaque
detected by DPMAS, and (D) the
solid phase of the plaque composed
mainly of CE mixtures obtained by
CPMAS. The number of scans was
12,288 for each spectrum. All spectra
were obtained at 37°C.
B. NZW rabbit artery with erly lesions, oily phase (off-MAS)
C=o
A. NormalNZW rabbit artery (DPMAS)
-r l T
75 50 25
phase would be too weak to be observed. The signal-to-
noise ratio in the plaque spectrum is also too low for CHOL
dissolved in CE to be observed, and, as shown above (Fig.
3 C and D), the solubility of CHOL in liquid CE is reduced
in liquid-crystalline CE. The amount of CHOL in this sam-
ple that is possibly crystalline (<1 mg) is likely also too
small to be detected. Although signals of the crystalline
CHOL would be enhanced by CP, the splitting of signals
(e.g., C5, C6, and C18) decreases the signal-to-noise ratio
relative to that of CE. In recent studies of human plaques
containing much higher total amounts of CHOL/mg of
tissue and higher CHOL/phospholipid ratios, CPMAS spec-
tra have revealed crystalline CHOL in the monohydrate
form (Hamilton et al., 1996).
These spectra of rabbit plaques provide more details
about the organization and phase behavior than do previous
NMR studies, which observed only the liquid phase above
body temperature (Kroon et al., 1982). Our observation that
CE is present in liquid-crystalline and solid states at the
same temperature indicates the coexistence of heteroge-
neous lipid pools: pools rich in cholesteryl linoleate re-
mained in the liquid-crystalline state, whereas pools rich in
cholesteryl oleate and saturated esters solidified. In some
atherosclerotic plaques, minor plaque lipid components
such as triglycerides may lower the liquid-to-liquid-crystal-
line phase transition temperature and may also prevent
crystallization of CE. The phase behavior of the cholesteryl
esters in our sample, as reflected in the spectra of Fig. 7 C
and D, shows that little of the observed triglyceride (Fig. 7
B) was co-mixed with the CE in plaques. Such triglyceride
can exist as fat cells outside the actual plaque. A similar
observation was made for human atherosclerotic plaque
(Hamilton et al., 1978). The spectra obtained of rabbit arterial
lesions demonstrate the feasibility of the MAS NMR protocol
for enhanced detection of lipids in intact human plaques.
SUMMARY
Free cholesterol, cholesteryl esters, triglyceride, and phos-
pholipids are the important lipid components of human
atherosclerotic lesions. Depending on the lipid composition
and the sample temperature, the lipid components can exist
in crystalline, liquid-crystalline, or isotropic phases. A
solid-state NMR with magic-angle-sample spinning proto-
col has been developed to study the crystalline structures of
free cholesterol, the molecular interactions of cholesterol
with other lipids in both the liquid-crystalline state and the
isotropic state, and the simultaneous identification of coex-
isting multiphases of individual lipid species. Based on the
results of model systems, an early atherosclerotic lesion
from New Zealand White rabbit arterial tissue was investi-
gated, and various lipid components and the corresponding
phases were identified.
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